Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

JHS Svendgaard Laboratories Ltd. Call Transcript 2023

Nov 2, 2023

61621_rns_2023-11-02_ae14f176-fb37-463d-9c6c-80f4fae80d8a.pdf

Call Transcript

Open in viewer

Opens in your device viewer

==> picture [108 x 80] intentionally omitted <==

CIN : L74110HP2004LC027558

November 02, 2023

To

The Listing Department Bombay Stock Exchange Limited Department of Corporate Services Phiroze Jeejeebhoy Towers, Dalal Street Mumbai – 400001

The Listing Department National Stock Exchange of India Limited Exchange Plaza, C-1, Block-G Bandra Kurla Complex Mumbai – 400051

Trading Symbol: JHS

Scrip Code: 532771

Subject: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure – Requirements) Regulations, 2015 Intimation of Earnings Conference Call.

Pursuant to Regulation 30(6) and 46(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a Conference Call for the analysts and investors to discuss the financial and operational performance of the Company for Q2 & H1 FY 2024 is scheduled to be held on November 08, 2023 at 02:00 PM IST. Further details are enclosed herewith.

Please note that the above shall be subject to changes in case of exigencies, if any, on the part of Investors/Company. The transcript of the aforesaid call shall be submitted to the Stock Exchange and placed on the website of the Company https://www.svendgaard.com .

This is for your information and records.

Thanking You,

For JHS Svendgaard Laboratories Limited

Digitally signed by KOMAL JHA KOMAL JHA Date: 2023.11.02 15:56:15 +05'30'

Komal Jha

Company Secretary & Compliance officer

Encl: A/a

==> picture [489 x 49] intentionally omitted <==

==> picture [97 x 59] intentionally omitted <==

JHS Svendgaard Laboratories Limited

Cordially invites you to the

Earnings Conference Call

To discuss the operational and financial performance for Q2 & H1 FY24

Day/Date: Wednesday 8[th] November 2023 Time: 02:00 PM

Access Numbers Access Numbers
Universal Dial in +91 22 6280 1102
+91 22 7115 8003
HongKong 800 964 448
Singapore 800 101 2045
UK 0808101 1573
USA 1866 746 2133

Diamond Pass Link:

https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=13 30501&linkSecurityString=7a15679d3

JHS Svendgaard Laboratories will be represented by:

Mr. Nikhil Nanda

Founder & Managing Director

Mr. Ashish Goel

Chief Financial Officer

We look forward to your participation

RSVP

Savli Mangle Adfactors PR

Contact: +91 98333 61003